Paper40679263
Low Specific T-Cell Immunity Against Mpox Elicited in People With HIV-1 and PrEP Users After Subcutaneous Vaccination Compared to Natural Infection.
Calle-Jiménez O and 16 others. J Med Virol, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Low Specific T-Cell Immunity Against Mpox Elicited in People With HIV-1 and PrEP Users After Subcutaneous Vaccination Compared to Natural Infection. Papers, record 40679263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40679263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| HIV Infections | Major topic |
| Immunity, Cellular | Major topic |
| Mpox, Monkeypox | Major topic |
| Adult | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Young Adult | |
| CD4-Positive T-Lymphocytes | |
| CD8-Positive T-Lymphocytes | |
| HIV-1 | |
| Injections, Subcutaneous | |
| Interferon-gamma | |
| Interleukin-2 | |
| Pre-Exposure Prophylaxis | |
| Vaccination |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
This work was supported by NIH grant R01AI143567; the Spanish Ministry of Science and Innovation, grant PID2022-141317OB-I00 funded by MICIU/AEI /10.13039/501100011033 and the European Regional Development Fund (ERDF), EU; the project ICI24CIII/00003 funded by the Intramural Strategic Action in Health of the Instituto de Salud Carlos III (ISCIII) and co-funded by the European Regional Development Fund (ERDF) "A way to make Europe"; and CIBERINFEC (Strategic Action for Mpox), Consorcio Centro de Investigación Biomédica en Red- (CB 2021), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea - NextGenerationEU, co-financed by the European Regional Development Fund (ERDF) "A way to make Europe". The work of Olivia de la Calle-Jiménez is financed by CIBERINFEC (CB21/13/00126). The work of Guiomar Casado is financed by the Consejería de Educación, Universidades, Ciencia y Portavocía of the Comunidad de Madrid. The work of Luis Lemus-Aguilar is financed by FPI grant for training of research staff associated to PID2022-141317OB-I00 (MICIU/AEI /10.13039/501100011033). The work of Montserrat Torres is financed by CIBERINFEC (CB21/13/00015). | PubMed | PubMed | |||
| R01 AI143567 | NIAID NIH HHS | United States | R01AI143567 | PubMed | NIH RePORTER |
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22884034 | Comparative pathology of smallpox and monkeypox in man and macaques. | J Comp Pathol | 2013 | https://conductscience.org/library/papers/22884034 | PubMed |
| 2 | 37475115 | Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study. | Lancet Infect Dis | 2023 | https://conductscience.org/library/papers/37475115 | PubMed |
| 3 | 36271768 | Human monkeypox (hMPXV) re-emergence: Host immunity status and current vaccines landscape. | J Med Virol | 2023 | https://conductscience.org/library/papers/36271768 | PubMed |
| 4 | 37227964 | Potential for Recurrent Mpox Outbreaks Among Gay, Bisexual, and Other Men Who Have Sex with Men - United States, 2023. | MMWR Morb Mortal Wkly Rep | 2023 | https://conductscience.org/library/papers/37227964 | PubMed |
| 5 | 25600603 | Cytokine modulation correlates with severity of monkeypox disease in humans. | J Clin Virol | 2015 | https://conductscience.org/library/papers/25600603 | PubMed |
| 6 | 38150509 | Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination. | J Med Virol | 2024 | https://conductscience.org/library/papers/38150509 | PubMed |
| 7 | 36344361 | Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo. | Vaccine | 2022 | https://conductscience.org/library/papers/36344361 | PubMed |
| 8 | 35653347 | Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. | MMWR Morb Mortal Wkly Rep | 2022 | https://conductscience.org/library/papers/35653347 | PubMed |
| 9 | 37199451 | Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States. | N Engl J Med | 2023 | https://conductscience.org/library/papers/37199451 | PubMed |
| 10 | 36201401 | Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022. | MMWR Morb Mortal Wkly Rep | 2022 | https://conductscience.org/library/papers/36201401 | PubMed |
| 11 | 37906357 | Changes in Sexual Behaviors Due to Mpox: a Cross-Sectional Study of Sexual and Gender Minority Individuals in Illinois. | Prev Sci | 2024 | https://conductscience.org/library/papers/37906357 | PubMed |
| 12 | 37117161 | Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37117161 | PubMed |
| 13 | 36851124 | Epidemiologic Situation of HIV and Monkeypox Coinfection: A Systematic Review. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36851124 | PubMed |
| 14 | 16203869 | Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. | J Exp Med | 2005 | https://conductscience.org/library/papers/16203869 | PubMed |
| 15 | 36860856 | Alterations in the immune system persist after one year of convalescence in severe COVID-19 patients. | Front Immunol | 2023 | https://conductscience.org/library/papers/36860856 | PubMed |
| 16 | 35777659 | Monkeypox virus: A novel sexually transmitted disease? A case report from France. | Travel Med Infect Dis | 2022 | https://conductscience.org/library/papers/35777659 | PubMed |
| 17 | 35866746 | Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35866746 | PubMed |
| 18 | 38857615 | Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study. | Lancet Microbe | 2024 | https://conductscience.org/library/papers/38857615 | PubMed |
| 19 | 36720271 | Real-world effectiveness of a single dose of mpox vaccine in males. | Nat Med | 2023 | https://conductscience.org/library/papers/36720271 | PubMed |
| 20 | 28414780 | Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue. | PLoS One | 2017 | https://conductscience.org/library/papers/28414780 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42414509 | MPXV H3L elicits broadly directed CD4 T cell responses in mpox patients and MVA vaccinees. | Npj Viruses | 2026 | https://conductscience.org/library/papers/42414509 | PubMed |
| 42207442 | CircRNA based bi-antigen vaccines against mpox virus induce potent and durable cross-protection in mice. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42207442 | PubMed |
| 41428316 | Exploration of the protein and pharmacological landscape of monkeypox virus treatment: from entry point to end point. | Mol Divers | 2026 | https://conductscience.org/library/papers/41428316 | PubMed |
| 41012133 | Immune Response to MVA-BN Vaccination for Mpox: Current Evidence and Future Directions. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012133 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40679263
GET https://conductscience.org/api/papers/v1/40679263/references?page=2